“Technological Advancements and Shift Toward Minimally Invasive Procedures”
- A significant and accelerating trend in the global endovascular stent grafts market is the increasing adoption of minimally invasive vascular interventions, which are gradually replacing traditional open surgical procedures due to faster recovery, reduced hospital stays, and lower procedural risks
- Endovascular stent grafts are becoming the preferred choice for treating aortic aneurysms and dissections, as they offer precise deployment, reduced intraoperative blood loss, and fewer complications. This shift is being strongly supported by advancements in catheter-based delivery systems, hybrid imaging guidance, and patient-specific graft customization
- The emergence of branched and fenestrated stent grafts has expanded the treatable population, especially for patients with complex aortic anatomies that were previously inoperable using conventional endovascular methods. These innovative grafts allow for better alignment with aortic branches, preserving blood flow while ensuring aneurysm exclusion
- Furthermore, the growing use of intravascular ultrasound (IVUS), 3D imaging, and robotic-assisted techniques is enhancing the accuracy and safety of endovascular procedures, prompting healthcare providers to increase their adoption across both high-income and developing countries
- The global burden of cardiovascular diseases, particularly aneurysmal conditions, continues to rise with an aging population, sedentary lifestyles, and increased tobacco use—amplifying demand for effective, low-risk treatment options such as endovascular stent grafts
- As healthcare systems aim to improve procedural efficiency and patient outcomes, manufacturers are focusing on the development of next-generation grafts with improved durability, flexibility, and adaptability to varied anatomical profiles, reinforcing the market’s upward trajectory across hospitals and ambulatory surgical centers globally
